Live Webinar

Comparing Bispecific Antibody Format Feasibility

We would like to invite you to participate in our partner company Absolute Antibody's upcoming webinar on bispecific antibody format feasibility.

Absolute Antibody Webinar: Comparing Bispecific Antibody Format Feasibility

Not every antibody can be combined to produce well-behaved multi-specifics. The valency and geometry of each design can determine the production, target engagement and ultimately the requisite biological functions. In this case study, we selected two established antibody therapeutics, trastuzumab and a humanized OKT3 to produce 17 different bispecific formats to compare the feasibility of each format.

Speaker: Ed Horton, Ph.D., Chief Commercial Officer, Absolute Antibody

Date and Time: Thursday, August 03, 2023, 10:00 AM CEST

Sign up to the webinar